Document is current
Any future updates will be listed below
-
Authors
Sullivan, Michael K. http://orcid.org/0000-0002-3800-2330
Carrero, Juan-Jesus
Jani, Bhautesh Dinesh
Anderson, Craig
McConnachie, Alex
Hanlon, Peter
Nitsch, Dorothea
McAllister, David A.
Mair, Frances S.
Mark, Patrick B.
Gasparini, Alessandro
-
Funding
Funding for this research was provided by:
Medical Research Council (MR/V001671/1, MR/S021949/1)
Vetenskapsrådet (2019-01059)
- License Information
-
More Information
Article History
Received: 10 October 2022
Accepted: 24 October 2022
First Online: 1 November 2022
Declarations
:
: For SCREAM, the Regional Ethics Review Board in Stockholm approved the study; informed participant consent was not deemed necessary since all data were de-identified at the Swedish Board of Health and Welfare. For SAIL, Swansea University’s Health Information Research Unit Information Governance Review Panel granted approval for this study as part of project 0830.
: Not applicable.
: DN reports fees from GSK, outside the submitted work; PBM reports personal fees and non-financial support from Vifor; personal fees from Astrazeneca, Astellas, Novartis and Janssen; grants from Boehringer Ingelheim; personal fees and non-financial support from Pharmacosmos; and personal fees and non-financial support from Napp, outside the submitted work; MKS, AM, BDJ, JJC, FSM, PH, AG, CA and DAM have nothing to disclose.
